Irinotecan: all 829 studies that test it

Page 9 of 9. Open to participants first (121), then studies with results posted, then the rest; newest registration first within each.

• Irinotecan in Treating Patients With Esophageal or Stomach CancerCompletedNCT00003748Phase 2
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00003742Phase 1
• Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue SarcomaStatus unknownNCT00003719Phase 2
• Combination Chemotherapy in Treating Patients With Metastatic Solid TumorsCompletedNCT00003711Phase 1
• Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid TumorsCompletedNCT00003710Phase 1
• Irinotecan in Treating Patients With Progressive or Recurrent Malignant GliomaCompletedNCT00003616Phase 1/2
• Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00003594Phase 3
• Irinotecan in Treating Patients With Metastatic Colorectal CancerCompletedNCT00003544Phase 2
• Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade GliomasCompletedNCT00003463Phase 1
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerCompletedNCT00003427Phase 1
• Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the PelvisCompletedNCT00003368Phase 1
• Irinotecan in Treating Patients With Refractory Metastatic Breast CancerCompletedNCT00003351Phase 2
• Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal CancerCompletedNCT00003345Phase 2
• Radiation Therapy Plus Irinotecan in Treating Patients With Colon CancerCompletedNCT00003344Phase 1/2
• Irinotecan in Treating Patients With Recurrent Malignant GliomaCompletedNCT00003301Phase 1/2
• Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct CancerCompletedNCT00003276Phase 2
• Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaCompletedNCT00003245Phase 2
• Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal CancerCompletedNCT00003225Phase 1/2
• Irinotecan in Treating Patients With Advanced Cancer of the StomachCompletedNCT00003137Phase 2
• Irinotecan in Treating Patients With Recurrent GliomaCompletedNCT00003134Phase 2
• Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung CancerCompletedNCT00003111Phase 2
• Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid TumorsCompletedNCT00003109Phase 1
• Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric CancerCompletedNCT00003055Phase 2
• Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant GliomaCompletedNCT00002988Phase 1
• Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent CancerCompletedNCT00002939Phase 1
• Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00002933Phase 2
• Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid TumorsCompletedNCT00002902Phase 1
• Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or LymphomaCompletedNCT00002759Phase 1
• A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid TumorsCompletedNCT00001495Phase 1

← Irinotecan overview